Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03779555 · ClinicalTrials.gov registry record
Lenalidomide Adherence in Older Adults
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 17
- Enrollment target
NCT03779555: Clinical Trial study, sponsored by Washington University School of Medicine.
NCT03779555 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03779555 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.
Primary Outcome
-Participants will be given a pill diary in which they will record if they opened the pill bottle without taking a medication (e.g. to ascertain remaining supply) to adjust the adherence rate accordingly
Interventions
- OTHER Medication Event Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-12-13 |
| Est. Completion | 2020-08-31 |
Why NCT03779555 stopped before completion
NCT03779555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Medication Event Monitoring System is the first listed.
NCT03779555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03779555 about?
NCT03779555 is a clinical study titled "Lenalidomide Adherence in Older Adults". To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.
What is the current status of trial NCT03779555?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2019-12-13. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03779555?
The interventions under investigation include: Medication Event Monitoring System (OTHER).
Who is sponsoring clinical trial NCT03779555?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI